ATC Group: A10BH02 Vildagliptin

Anatomical Therapeutic Chemical Classification System

Translations

Language
Translation
  English
Vildagliptin

Hierarchical Position

Active Ingredients

Chemical substance
Description

Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).